Predicted to enable CCR2 chemokine receptor binding activity; heparin binding activity; and lipopolysaccharide binding activity. Predicted to be involved in antifungal innate immune response; defense response to Gram-negative bacterium; and defense response to Gram-positive bacterium. Predicted to be located in microvesicle and nucleus. Predicted to be extrinsic component of membrane. Orthologous to human DEFB106B (defensin beta 106B). [provided by Alliance of Genome Resources, Apr 2022]